TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Clinical trial NCT02574663 · COMPLETED
Trial details
- NCT number
- NCT02574663
- Sponsor
- TG Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-11
- Primary completion
- 2018-08-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.